November 22, 2002
Fifty healthy HIV-negative volunteers between 18 and 40 are needed for the first trial, which will be conducted at the National Institutes of Health in Bethesda, Maryland. This placebo-controlled trial will check for safety and also for immune responses to HIV. Later trials will run in several U.S. sites, as well as in Haiti and South Africa.
Copyright 2002 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.
ISSN # 1052-4207
Back to the AIDS Treatment News November 22, 2002 contents page.